A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USA.
Simon Andreas Dalla Torre di SanguinettoEsa HeinonenJanine AntonovClaus BoltePublished in: Therapeutic innovation & regulatory science (2018)
The 3 investigated DRAs adhere largely to the same scientific principles and regulatory guidelines; therefore, remaining disparities ought to be considered in a cultural, legal and public health priority context.